
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1056 | 1049 | 1107 | 1107 | 1208 | 1853 |
Fund Return | 5.65% | 4.93% | 10.67% | 3.46% | 3.85% | 6.36% |
Place in category | 71 | 254 | 251 | 174 | 152 | 79 |
% in Category | 16 | 63 | 71 | 55 | 53 | 32 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
FC Responsible Global Equity 1 Acc | 1.09B | 13.07 | 1.31 | 10.91 | ||
FC Responsible Global Equity 1 Inc | 1.09B | 4.50 | 5.84 | 10.91 | ||
FC Responsible Global Equity 2 Acc | 1.09B | 13.95 | 2.10 | 11.83 | ||
FC Responsible Global Equity 4 Inc | 1.09B | 14.76 | 2.83 | 12.59 | ||
FC Responsible Global Equity Fund 2 | 1.09B | -8.28 | 1.74 | 9.71 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Artemis UK Select Fund I Acc | 1.88B | 0.90 | 12.67 | 9.00 | ||
Artemis UK Select Fund G Inc GBP | 753.69M | 5.79 | 13.25 | - | ||
Artemis UK Select Fund R Acc | 211.31M | 5.69 | 12.10 | 9.10 | ||
Artemis UK Select Fund I Inc GBP | 219.59M | 25.31 | 10.43 | 9.44 | ||
Fidelity Special Situations Fund W | 3.11B | 1.22 | 8.90 | 6.97 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 6.32 | 10,280.0 | -0.39% | |
Unilever | GB00B10RZP78 | 4.96 | 54.90 | +0.66% | |
HSBC | GB0005405286 | 3.61 | 783.50 | +1.63% | |
Relx | GB00B2B0DG97 | 3.45 | 3,896.00 | +3.01% | |
Compass | GB00BD6K4575 | 3.16 | 2,557.00 | +1.43% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Neutral |
Technical Indicators | Neutral | Strong Sell | Neutral |
Summary | Neutral | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review